| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 06/14/2001 | CA2392584A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/13/2001 | EP1106210A2 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
| 06/13/2001 | EP1105728A1 Modulating multiple lineage kinase proteins |
| 06/13/2001 | EP0805812B1 Bicyclic substituted hexahydrobenz(e)isoindole alpha-1- adrenergic antagonists |
| 06/13/2001 | EP0711295B1 Method for the preparation of 9-amino camptothecin |
| 06/13/2001 | CN1067070C Coralyne analogs as topoisomerase inhibitors |
| 06/13/2001 | CN1067053C Process for preparing intermediate of derivatives of monocyclic beta-lactam antibiotics |
| 06/12/2001 | US6245796 Tricyclic pyrrole or pyrazole derivative |
| 06/12/2001 | US6245781 Administering berberine |
| 06/12/2001 | US6245773 Benign prostatic hyperplamia; reduction of intraocular pressure |
| 06/12/2001 | CA2215982C Nodulisporic acid derivatives |
| 06/07/2001 | WO2001040217A1 Novel benzoimidazole derivatives useful as antiproliferative agents |
| 06/07/2001 | WO2001039759A2 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| 06/07/2001 | CA2327575A1 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
| 06/06/2001 | EP1104764A1 1h-imidazopyridine derivatives |
| 06/06/2001 | EP1104755A1 Process for the preparation of (S)-N-tertbutyl-1,2,3,4- tetrahydroisoquinoline-3-carboxamide |
| 06/06/2001 | EP1104754A1 Novel sulfonyl derivatives |
| 06/06/2001 | EP1104423A1 Anhydride modified cantharidin analogues useful in the treatment of cancer |
| 06/06/2001 | EP1104410A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
| 06/06/2001 | EP1104297A1 Methods and compositions for the treatment of chronic lymphocytic leukemia |
| 06/06/2001 | EP0888346B1 Coralyne analogs as topoisomerase inhibitors |
| 06/06/2001 | EP0737188B1 Arthropodicidal oxadiazine carboxanilides |
| 06/06/2001 | CN1298398A 12,13-modified epothilone derivatives |
| 06/06/2001 | CN1298393A Quinoline derivatives |
| 06/06/2001 | CN1298390A Arylphenyl-substituted cyclic keto-enols |
| 06/06/2001 | CN1066625C Therapeutical use for benzopyran derivative |
| 06/05/2001 | US6242606 Reacting a a,a-dimethylphenylacetic acid amide with a w-halo compound produces w'-halo-a-keto-a,a-dimethylphenylacetic acid amide and reacting it with a piperidine compound; 2-(4-(4-chloro-butyryl)-phenyl)-2-methy-propionic acid |
| 06/05/2001 | US6242604 Process for preparing a morphinan derivative |
| 06/05/2001 | US6242481 Administering cytochalasin derivative as anticarcinogenic or antitumor agent |
| 06/05/2001 | US6242457 Oxime derivatives |
| 05/31/2001 | WO2001038332A1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors |
| 05/30/2001 | EP1103554A1 Derivatives of dihydrofuro-(3,4-b)-quinolein-1-ones, process of préparation and phamaceutical compositions containing them |
| 05/30/2001 | EP1102776A1 Water soluble prodrugs of hindered alcohols or phenols |
| 05/30/2001 | EP1102768A1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings |
| 05/30/2001 | EP1102590A1 Use of a nk-1 receptor antagonist for treating or preventing abnormal bone resorption |
| 05/30/2001 | EP1102535A2 Compounds and methods |
| 05/30/2001 | CN1297451A Glucocorticoid-selective antiinflammatory agents |
| 05/30/2001 | CN1297350A Agents for relieving side effects |
| 05/30/2001 | CN1066451C Thiazoline deriv. composition and use thereof |
| 05/29/2001 | US6239306 Phenylsulfonylureas, processes for their preparation, and their use as herbicides and plant growth regulations |
| 05/29/2001 | US6239278 Intermediates in the synthesis of (±)-camptothecin and related compounds and synthesis thereof |
| 05/29/2001 | US6239139 13,13A-Didehydroberbine derivatives |
| 05/25/2001 | WO2001036423A1 Spiro(2h-1-benzopyran-2,4'-piperidine) derivates as glycine transport inhibitors |
| 05/25/2001 | WO2001036422A1 Tricyclic dihydropyrimidine potassium channel openers |
| 05/25/2001 | WO2000039081A3 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/25/2001 | CA2391291A1 Tricyclic dihydropyrimidine potassium channel openers |
| 05/23/2001 | EP1101770A1 Derivatives of 12,13-(pyranosyl)-indolo(2,3-a)pyrrolo(3,4-c)carbazole and 12,13-(pyranosyl)-furo(3,4-c)indolo(2,3-a)carbazole, their process of preparation and pharmaceutical compositions containing them |
| 05/23/2001 | EP1101765A2 Camptothecin analogues, process for their preparation and pharmaceutical compositions containing them |
| 05/23/2001 | EP1101759A1 Phenylazole compounds, process for producing the same and drugs for hyperlipemia |
| 05/23/2001 | EP1101758A1 Fused-heterocycle dicarboxylic diamide derivatives or salts thereof, herbicides and usage thereof |
| 05/23/2001 | EP1100805A1 Medicine nitrate salts |
| 05/23/2001 | EP1100799A1 Preparation of camptothecin and nothapodytine derivatives |
| 05/23/2001 | EP1100781A1 High affinity ligands for nociceptin receptor orl-1 |
| 05/23/2001 | EP1100504A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 05/23/2001 | EP1100495A1 Propenamides as ccr5 modulators |
| 05/23/2001 | EP1100485A1 Substituted anilide compounds and methods |
| 05/23/2001 | CN1296486A Glucocorticoid-selective anti-inflammatory agents |
| 05/23/2001 | CN1296483A Febrifugine and isofebrifugine and processes for the preparation of both |
| 05/23/2001 | CN1296409A Treatment of panic attacks |
| 05/23/2001 | CN1066168C Enhancing the storage stability of organic phosphites and phosphonites |
| 05/23/2001 | CN1066148C Tricyclic benzazepine compounds |
| 05/23/2001 | CN1066142C 喹唑啉衍生物 Quinazoline derivatives |
| 05/23/2001 | CN1066141C 3-(hetero)aryl carboxylic acid derivatives, methods of preparing them and intermediates used in their preparation |
| 05/22/2001 | US6235907 Intermediates useful in making mappicine and related compounds |
| 05/22/2001 | US6235765 Benzimidazole derivatives |
| 05/22/2001 | US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide |
| 05/22/2001 | US6235748 Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| 05/22/2001 | US6235740 Autoimmune diseases; antiproliferation agents |
| 05/17/2001 | WO2001034609A1 Heterocyclically anellated indenochromene derivatives |
| 05/17/2001 | WO2001034591A2 Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/17/2001 | WO2001034573A1 Compounds |
| 05/16/2001 | EP1098870A2 Nitric esters and nitrate salts of specific drugs |
| 05/16/2001 | EP1098662A2 Coadministration of acat and mmp inhibitors for the treatment of atherosclerotic lesions |
| 05/16/2001 | EP0798288B1 Triciclic compounds |
| 05/16/2001 | CN1295573A Pharmaceutically available protoberberine salt derivatives, and protoberberine derivatives and salt thereof |
| 05/16/2001 | CN1295072A New polycyclic system compound as neurotransmitter release reinforcer in treatment of identification fault and derivatives thereof |
| 05/16/2001 | CN1295071A Condensed imidezo-[1,2-a] pyridines |
| 05/15/2001 | US6232322 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 05/15/2001 | US6232308 Useful for inhibiting bone resorption, treating and preventing osteoporosis, inhibiting vascular restenosis, diabetic retinopathy, macular degeneration, and angiogenesis |
| 05/15/2001 | CA2196539C Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
| 05/10/2001 | WO2001032783A1 Water-soluble rhodamine dyes and conjugates thereof |
| 05/10/2001 | WO2001032661A1 Naphthopyrans with a heterocycle in the 5,6-position, preparation, and compositions and matrices containing them |
| 05/10/2001 | WO2001032653A1 Heterocyclic substituted pyrazolones |
| 05/10/2001 | WO2001032632A2 Pharmaceutically active 4-substituted pyrimidine derivatives |
| 05/10/2001 | WO2001032631A2 Heterocyclic cytotoxic agents |
| 05/10/2001 | WO2001004122A3 New 2,3-benzodiazepine derivatives |
| 05/10/2001 | WO1999002514A3 Epothilone derivatives |
| 05/10/2001 | US20010001100 For treating narrow-angle glaucoma, Alzheimer's disease, as well as alcohol and nicotine dependence |
| 05/10/2001 | CA2389807A1 Heterocyclic substituted pyrazolones |
| 05/10/2001 | CA2389764A1 Naphthopyrans with a heterocycle in the 5,6-position, preparation, and compositions and matrices containing them |
| 05/10/2001 | CA2389312A1 Heterocyclic cytotoxic agents |
| 05/09/2001 | EP1097928A1 5-(2,3-Dialkoxyphenyl)-4,1-benzoxazepin-2-ones as anti-hyperlipidemics |
| 05/09/2001 | EP1097154A1 Substituted benzimidazoles, production and use thereof as agents for combating parasitic protozoas |
| 05/08/2001 | US6228861 Benign prostatic hyperplasia; anticholesterol agents; impotency; intraocular pressure; antiarrhythmia agents |
| 05/08/2001 | US6228855 Topoisomerase inhibitors; antitumor agents |
| 05/03/2001 | WO2001030753A2 Enhancement of production of camptothecins from plants |
| 05/03/2001 | WO2001012607A3 Pharmaceutical compositions comprising 4-quinolones for treating cancers |
| 05/02/2001 | EP1095656A2 Pharmaceutical preparation comprising Galanthamine as cholinesterase inhibitor |
| 05/02/2001 | EP1095044A1 Piperazynil pyrimidine dione compounds selective for adrenoceptors |
| 05/02/2001 | EP1095043A1 Trioxane derivatives |